94 results on '"Tsyganov, M M"'
Search Results
2. Personalized adjuvant chemotherapy for stage II–III non-small cell lung cancer
3. Breast tumour cell subpopulations with expression of the MYC and OCT4 proteins
4. Human papillomavirus and lung cancer: an overview and a meta-analysis
5. HPV-associated cervical cancer: Current status and prospects
6. Combined modality treatment of patients with stage IV gastric cancer with peritoneal carcinomatosis
7. Expression heterogeneity of ABC-transporter family genes and chemosensitivity genes in gastric tumor, carcinomatosis and lymph node metastases
8. Prognostic and Predictive Significance of mRNA Expression of ABC-transporter Genes in Patients with Non-small Cell Lung Cancer
9. Natural and chemotherapy-induced clonal evolution of tumors
10. Predictive and prognostic significance of loss of heterozygosity in ABC transporter genes in breast cancer
11. Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy
12. Gastric cancer: modern approaches and prospects of treatment for peritoneal carcinomatosis (literature review)
13. Intratumor heterogeneity: Nature and biological significance
14. STUDY OF THE HUMAN PAPILLOMA VIRUS PREVALENCE AND ITS PHYSICAL STATUS IN PATIENS WITH NON-SMALL CELL LUNG CANCER
15. Aberrations of the number of copies (CNA) in the genome of luminal B breast tumor
16. Gene expression analysis of ABC transporter family in breast tumors: relationship with chemotherapy effect and disease prognosis
17. ASSOCIATION OF THE COMBINATION OF STEMNESS GENE AMPLIFICATIONS AND COPY NUMBER ABERRATIONS OF WNT-SIGNALING GENES IN BREAST TUMORS WITH METASTASIS
18. LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER
19. PARP1 inhibitors in breast cancer therapy. Mechanism of action and clinical use
20. Assessing survival rate of HPV-positive and HPV-negative cervical cancer patients
21. A PERSONALIZED APPROACH TO ADJUVANT CHEMOTHERAPY FOR NON-SMALL CELL LUNG CANCER AFTER RADICAL SURGICAL TREATMENT BASED ON MOLECULAR MARKERS OF CHEMOSENSITIVITY
22. IN VITRO MODELING OF TUMOR INTERCLONAL INTERACTIONS USING BREAST CANCER CELL LINES.
23. The prognostic significance of BRCA1 gene expression in patients with breast cancer
24. Human papillomavirus in head and neck cancer (literature review)
25. RESPONSE TO NEOADYAVANT CHEMOTHERAPY WITH PLATINUM-BASED DRUGS IN BREAST CANCER PATIENTS WITH BRCA1 DELETION IN TUMOR
26. mRNA expression of chemosensitivity genes as a predictor of response to neoadjuvant chemotherapy in non-small cell lung cancer
27. Physical status of human papillomavirus in the prognosis of recurrence of low-grade and-high-grade cervical intraepithelial lesions
28. BRCA1 mRNA expression levels as an predictor of response to neoadjuvant chemotherapy in breast cancer
29. The clinical observation of human papillomavirus positive breast tumor
30. Copy number aberrations landscape of a breast tumor, connection with the efficiency of neoadjuvant chemotherapy
31. ROLE OF TRANSFORMING GROWTH FACTOR RECEPTOR B I TYPE (TGF-BRI) IN THE PROGRESSION OF THE LUMINAL BREAST CANCER SUBTYPE
32. Long-term results of the head and neck squamous cell carcinomas treatment depending on the therapy
33. Expression of the BRCA1 gene in a breast tumor: Correlation with the effect of neoadjuvant chemotherapy
34. Phenomenon of loss of heterozygosity in tumour tissue of breast cancer: association with expression of monoresistance genes
35. EXPRESSION of MACROPHAGe-ASSOCIATED GENES IN BREAST TUMORS: RELATION TO TUMOR PROGRESSION
36. Integrative and episomal forms of genotype 16 of human papillomavirus in patients with cervical intraepithelial neoplasia and cervical cancer
37. PERSONALIZED APROACH TO POSTOPERATIVE CHEMOTHERAPY IN THE COMBINED MODALITY TREATMENT OF NON-SMALL CELL LUNG CANCER (CLINICAL CASE)
38. Effects of achilline on lipid metabolism gene expression in cell culture
39. Composite implants coated with biodegradable polymers prevent stimulating tumor progression
40. Invasive and drug resistant expression profile of different morphological structures of breast tumors
41. Microarray study of single nucleotide polymorphisms and expression of ATP-binding cassette genes in breast tumors
42. Disease-free and overall survival of patients diagnosed with HPV-associated or HPV-negative cervical cancer
43. Combined treatment of locally advanced non-small cell lung cancer and molecular aspects of chemoresistance
44. Prognostic significance of ERCC1, RRM1, TOP1, TOP2A, TYMS, TUBB3, GSTP1 and BRCA1 mRNA expressions in patients with non-small-cell lung cancer receiving a platinum-based chemotherapy
45. Connection of metastasis-free survival in breast cancer patients and an expression vector of multidrug resistance genes in tumor during neoadjuvant chemotherapy
46. Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy
47. Prognostic significance of monoresistance gene expression in the tumors of patients with small cell lung cancer after preoperative chemotherapy
48. Influence of sesquiterpene lactone grossgemin on the lipid metabolism in experimental hyperlipidemia caused by atherogenic feed in rats
49. Substantiation of Expressive Markers Use to Personalize Lung Cancer Chemotherapy
50. [Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.